CAMBRIDGE , Britain (AP) - CAMBRIDGE , Britain (AP) - Astrazeneca PLC (AZN) on Tuesday reported first-quarter profit of $2.92 billion . On a per-share ...
Angelini Acraf S.p.A. Competitors or Alternatives
Angelini Acraf S.p.A.'s top competitors include Menarini, Bracco S.p.A. and Chiesi.
Angelini Acraf S.p.A. VS Menarini
Menarini is seen as one of Angelini Acraf S.p.A.'s biggest rivals. Menarini was founded in 1886 in Florence, Other. Like Angelini Acraf S.p.A., Menarini also operates in the Biotechnology sector. Menarini generates $4.6B more revenue than Angelini Acraf S.p.A..
Angelini Acraf S.p.A. VS Bracco S.p.A.
Bracco S.p.A. is one of Angelini Acraf S.p.A.'s top competitors. Bracco S.p.A. was founded in 1927, and its headquarters is in Milan, Lombardy. Like Angelini Acraf S.p.A., Bracco S.p.A. also operates in the Pharmaceuticals space. Bracco S.p.A. has 3,786 more employees than Angelini Acraf S.p.A..
Looking for similar companies to Angelini Acraf S.p.A.?
Similar Companies
Biotechnology companies in Roma
See 10 companies
Biotechnology companies in ItalySee 436 companies
Pharmaceuticals & Biotechnology companies in RomaSee 24 companies
Pharmaceuticals companies in RomaSee 15 companies
Pharmaceuticals companies in ItalySee 554 companies
Pharmaceuticals & Biotechnology companies in ItalySee 959 companies
Biotechnology companies in EuropeSee 7,119 companies
Biotechnology companies in EMEASee 7,758 companies
Pharmaceuticals companies in EuropeSee 8,209 companies
Trending News for Angelini Acraf S.p.A. and Angelini Acraf S.p.A.'s Competitors
Merck estimates the project will create more than 500 full-time roles and about 4,000 construction jobs....
Roche announced that the US Food and Drug Administration (FDA) granted Breakthrough Device Designation for the VENTANA TROP2 (EPR20043) RxDx Device....
Annual General Meeting of April 30, 2025 Approval of the financial statements for the fiscal year 2024Distribution of a cash dividend of €3.92 per shar...
Eli Lilly (NYSE:LLY) is scheduled to release its earnings report on Thursday, May 1, 2025. For event-driven traders, historical stock performance follo...
Novartis plans to acquire Regulus Therapeutics for $7.00 per share in cash, or $800 million, the microRNA specialist said Wednesday. This is more than ...
The trial met its primary endpoint of event-free survival (EFS) by investigator assessment, demonstrating a clinically meaningful and statistically sig...
NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) announced the FDA has approved IMAAVY, a human FcRn-blocking monoclonal antibody, for the treatment o...
Bristol Myers Squibb (NYSE:BMY) recently reported its first-quarter results, with adjusted earnings of $1.80 per share on revenue of $11.2 billion. Thi...
Frequently Asked Questions about Angelini Acraf S.p.A.
Who are Angelini Acraf S.p.A.'s top competitors?
Angelini Acraf S.p.A.'s top 3 competitors are Menarini, Bracco S.p.A., Chiesi.Who is similar to Angelini Acraf S.p.A.?
Menarini is the most similar to Angelini Acraf S.p.A.. Bracco S.p.A. and Chiesi are also similar to Angelini Acraf S.p.A..
Are Angelini Acraf S.p.A. and Menarini competitors?
Yes, Menarini is one of Angelini Acraf S.p.A.’s top competitors.